Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Royalty Pharma plc
RPRX
$67.72
Name : Royalty Pharma plc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $38,938,304,512.00
EPSttm : 1.53
finviz dynamic chart for RPRX
Royalty Pharma plc
$67.72
1.38%
$0.95
RPRX — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

3.13

Margin Of Safety %

23

Put/Call OI Ratio

0.16

EPS Next Q Diff

0.24

EPS Last/This Y

3.6

EPS This/Next Y

0.52

Price

67.72

Target Price

74.43

Analyst Recom

1.5

Performance Q

10.46

Upside

-50.0%

Beta

0.35

Ticker: RPRX




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-21RPRX62.150.170.007527
2026-10-22RPRX63.740.170.007538
2026-10-23RPRX63.840.150.238098
2026-10-26RPRX64.780.150.038173
2026-10-27RPRX65.30.150.008173
2026-10-28RPRX64.810.150.168372
2026-10-29RPRX65.930.150.058383
2026-10-30RPRX67.180.150.018380
2026-11-02RPRX66.510.140.008491
2026-11-03RPRX66.360.140.088514
2026-11-04RPRX67.550.140.008524
2026-11-05RPRX67.550.140.218535
2026-11-06RPRX67.290.140.008580
2026-11-09RPRX68.780.140.088784
2026-11-10RPRX69.450.140.008943
2026-11-11RPRX700.140.018943
2026-11-12RPRX68.960.140.018900
2026-11-13RPRX69.290.170.007459
2026-11-16RPRX68.310.160.007775
2026-11-17RPRX68.660.160.037799
2026-11-18RPRX68.680.160.007776
2026-11-19RPRX67.730.160.807781
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-21RPRX62.240.6353.05.32
2026-10-22RPRX63.740.6360.05.32
2026-10-23RPRX63.840.6324.35.32
2026-10-26RPRX64.760.6343.25.32
2026-10-27RPRX65.290.6334.15.32
2026-10-28RPRX64.830.6323.65.32
2026-10-29RPRX65.950.6348.25.32
2026-10-30RPRX67.180.6350.85.32
2026-11-02RPRX66.530.6307.15.32
2026-11-04RPRX67.560.6349.45.32
2026-11-05RPRX67.540.6487.45.32
2026-11-06RPRX67.293.8482.85.32
2026-11-09RPRX68.783.8521.65.32
2026-11-10RPRX69.456.9553.05.39
2026-11-11RPRX69.976.9549.45.39
2026-11-12RPRX68.976.9514.95.39
2026-11-13RPRX69.306.9545.45.39
2026-11-16RPRX68.516.9518.75.39
2026-11-17RPRX68.666.9540.95.39
2026-11-18RPRX68.686.9538.15.39
2026-11-19RPRX67.726.9515.95.39
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-21RPRX-1.751.533.09
2026-10-22RPRX-1.751.533.09
2026-10-23RPRX-1.751.533.09
2026-10-26RPRX-2.251.483.08
2026-10-27RPRX-1.751.483.07
2026-10-28RPRX-1.751.483.07
2026-10-29RPRX-1.751.483.07
2026-10-30RPRX-1.751.483.07
2026-11-02RPRX-1.652.143.07
2026-11-03RPRX-1.652.143.07
2026-11-05RPRX-1.652.143.07
2026-11-06RPRX-1.652.143.07
2026-11-09RPRX-1.662.093.08
2026-11-10RPRX-1.662.093.08
2026-11-11RPRX-1.662.093.13
2026-11-12RPRX-1.662.093.13
2026-11-13RPRX-1.662.093.13
2026-11-16RPRX-1.623.223.13
2026-11-17RPRX-1.623.223.13
2026-11-18RPRX-1.623.223.13
2026-11-19RPRX-2.633.223.13
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS​

1.21

Avg. EPS Est. Current Quarter

1.57

Avg. EPS Est. Next Quarter

1.45

Insider Transactions

-2.63

Institutional Transactions

3.22

Beta

0.35

Average Sales Estimate Current Quarter

756

Average Sales Estimate Next Quarter

Fair Value

82.97

Quality Score

68

Growth Score

87

Sentiment Score

59

Actual DrawDown %

3.8

Max Drawdown 5-Year %

-42

Target Price

74.43

P/E

44.06

Forward P/E

11.49

PEG

1.1

P/S

14.85

P/B

4.42

P/Free Cash Flow

12.97

EPS

1.54

Average EPS Est. Cur. Y​

5.39

EPS Next Y. (Est.)

5.91

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

25.65

Relative Volume

0.88

Return on Equity vs Sector %

-16.7

Return on Equity vs Industry %

2

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.05

EBIT Estimation

515.9
◆ RPRX Healthcare
$67.72
📉
Swing / Pullback
Buy the dip on strong trends
29 /100
WEAK
Trend
0/20
Pullback
2/25
Volume
7/15
Valuation
10/20
TP/AR
4/10
Options
6/10
RSI
60.2
Range 1M
74.2%
🚀
Momentum Growth
Ride accelerating trends
N/A
39 /100
WEAK
Momentum
6/25
Growth
12/30
Estimates
7/20
Inst/Vol
7/15
Options
7/10
EPS Yr
11.9%
EPS NY
9.1%
52W%
92.5%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +54.7% upside
Quality
10/30
Valuation
20/30
Growth
11/25
Stability
4/10
LT Trend
1/5
Upside
+54.7%
Quality
68
MoS
23%
RPRX — P/E HistoricalBiotechnology
Royalty Pharma plc
Sector: Healthcare
Industry: Biotechnology
Employees: 100
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.
RPRX

Latest News

—
Caricamento notizie per RPRX…
stock quote shares RPRX – Royalty Pharma plc Stock Price stock today
news today RPRX – Royalty Pharma plc stock forecast ,stock prediction 2023 2024 2025
marketwatch RPRX – Royalty Pharma plc yahoo finance google finance
stock history RPRX – Royalty Pharma plc invest stock market
stock prices RPRX premarket after hours
ticker RPRX fair value insiders trading